48 studies found for:    CB1
Show Display Options
Rank Status Study
1 Completed PET Imaging of Cannabinoid CB1 Receptors Using [18F]FMPEP-d2
Conditions: CB1;   Cannabinoid;   PET;   [18F]FMPEP-d2;   Brain Imaging
Intervention: Drug: [18F]FMPEP-d2
2 Completed PET Imaging of Cannabinoid CB1 Receptors Using [11C]MePPEP
Condition: Healthy
Intervention: Drug: [11C]MePPEP
3 Terminated Imaging Cannabinoid CB1 Receptors in Schizophrenia
Condition: Schizophrenia
Intervention:
4 Recruiting Imaging Cannabinoid CB1 Receptors in Alcohol Dependence
Condition: Alcoholism
Intervention:
5 Terminated Imaging of CB1 Receptors Using (11C)SD5024
Condition: Healthy
Interventions: Procedure: Brain Scan-PET;   Procedure: Brain Scan-MRI;   Procedure: Arterial Line;   Procedure: Venous Line;   Procedure: Blood Sampling
6 Completed Cannabinoid Receptor (CB1) Agonist Treatment in Severe Chronic Anorexia Nervosa
Condition: Anorexia Nervosa
Interventions: Drug: dronabinol;   Drug: placebo
7 Completed Rimonabant to Reduce Alcohol Consumption
Conditions: Healthy;   Alcohol Drinking
Intervention: Drug: SR141716 (Rimonabant)
8 Completed Antagonistic Interaction CB1-paracetamol
Condition: Pain
Intervention: Drug: Rimonabant and Paracetamol and placebo
9 Recruiting Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Conditions: Schizophrenia;   Cannabis Dependence;   Prodromal for Psychotic Illness;   Family History of Alcoholism
Intervention: Radiation: [11-C]OMAR
10 Completed Neurobiology of Cannabis Dependence
Conditions: Cannabis Dependence;   Cannabis Withdrawal
Interventions: Drug: rimonabant;   Drug: placebo
11 Completed Imaging of Cannabinoid Receptors Using New Radioactive Tracer
Condition: Healthy
Intervention: Drug: [(11)C] MePPEP
12 Unknown  Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome
Condition: Prader-willi Syndrome
Interventions: Drug: rimonabant;   Drug: placebo
13 Completed Evaluation of [18F]MK-9470 as a Brain Tracer of Cannabinoid-1 Receptor in Parkinson's Disease and Healthy Subjects
Condition: Parkinson Disease
Intervention: Drug: [18F]MK-9470
14 Completed Neuroprotection by Cannabinoids in Huntington's Disease
Condition: Huntington's Disease
Interventions: Drug: delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD);   Drug: Placebo
15 Not yet recruiting The Pharmaco-genetic and Brain Mechanisms Associated With Cannabis- Induced Psychosis
Conditions: Cannabis Dependence;   Psychosis
Intervention:
16 Active, not recruiting Imaging of Cannabinoid 1 Receptors Using [11C]OMAR and PET
Conditions: Obesity;   Alcohol Dependence;   High Stress
Intervention: Drug: [C-11]OMAR
17 Completed Efficacy and Safety of Surinabant Treatment as an Aid to Smoking Cessation (SURSMOKE)
Condition: Smoking Cessation
Interventions: Drug: surinabant (SR147778);   Drug: placebo
18 Completed Phase 1 Pharmacokinetic Study Of CP-945598 In Patients With NASH
Condition: Non-Alcoholic Steatohepatitis(NASH)
Interventions: Drug: Active treatment;   Drug: Placebo
19 Completed Paracetamol CSF Pharmacokinetics Study
Condition: Paracetamol
Intervention: Drug: Administration of paracetamol
20 Terminated Efficacy and Safety of AVE1625 as a Co-treatment With Antipsychotic Therapy in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: AVE1625;   Drug: placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years